INCRELEX Side Effects

7028192-9 | Eye Swelling, Glaucoma
on Sep 17, 2010 Male patient from UNITED STATES , 13 years of age, was treated with Increlex (View Usage). Patient experienced the following unwanted or unexpected effects: eye swelling, glaucoma (What is glaucoma?). Increlex dosage: .

6992366-3 | Hyperhidrosis, Hypoglycaemia, Lip Discolouration, Loss Of Consciousness, Malaise, Skin Discolouration
Patient was taking Increlex (View Usage). Patient had the following side effects: hyperhidrosis, hypoglycaemia, lip discolouration, loss of consciousness, malaise, skin discolouration on Sep 01, 2010 from UNITED STATES Additional patient health information: Male patient , child 2 years of age, weighting 24.91 lb, was diagnosed with insulin-like growth factor decreased and. Increlex dosage: 8 Units (4 Units, 2 In 1 D), Subcutaneous, (4 Units,at Least Once Per Day), Subcutaneous.

6972631-6 | Hypoglycaemia, Loss Of Consciousness
Adverse event was reported on Aug 25, 2010 by a Male patient taking Increlex (View Usage) (Dosage: 8 Units (4 Units, 2 In 1 D), Subcutaneous) was diagnosed with insulin-like growth factor decreased and. Location: PUERTO RICO , child 2 years of age, After Increlex was administered, patient had the following side effects: hypoglycaemia, loss of consciousness.

6970185-1 | Iga Nephropathy
on Aug 23, 2010 Male patient from GERMANY , 13 years of age, weighting 77.16 lb, was diagnosed with insulin-like growth factor decreased and was treated with Increlex (View Usage). Patient experienced the following unwanted or unexpected effects: iga nephropathy. Increlex dosage: 40 Mg (20 Mg, 2 In 1 D), Subcutaneous. Patient was hospitalized.


6959626-3 | Iga Nephropathy
on Aug 13, 2010 Male patient from GERMANY , 13 years of age, weighting 77.16 lb, was diagnosed with insulin-like growth factor decreased and was treated with Increlex (View Usage). Patient had the following side effects: iga nephropathy. Increlex dosage: 40 Mg (20 Mg,2 In 1 D),subcutaneous. Patient was hospitalized.

6932976-2 | Benign Intracranial Hypertension, Constipation, Decreased Appetite, Neutrophil Count Decreased
Patient was taking Increlex (View Usage). After Increlex was administered, patient had the following side effects: benign intracranial hypertension, constipation (What is constipation?), decreased appetite, neutrophil count decreased on Aug 02, 2010 from UNITED STATES Additional patient health information: Male patient , child 11 years of age, weighting 55.12 lb, was diagnosed with insulin-like growth factor decreased and. Increlex dosage: Maximum Dose Received = 2.7 Mg Bid (2.7 Mg), Subcutaneous. During the same period patient was treated with ZANTAC (RANITDINE HYDROCHLORIDE) (View Zantac (ranitdine Hydrochloride) Review and Zantac (ranitdine Hydrochloride) Label ), MILK OF MAGNESIA (MAGNESIIM HYDROXIDE) (View Milk Of Magnesia (magnesiim Hydroxide) Review and Milk Of Magnesia (magnesiim Hydroxide) Label ), MIRALAX (View Miralax Review and Miralax Label ), EX LAX (SENNA ALEXANDRINA) (View Ex-lax (senna Alexandrina) Review and Ex-lax (senna Alexandrina) Label ), DIAMOX (View Diamox Review and Diamox Label ).

6930246-X | Clonus
Adverse event was reported on Jul 29, 2010 by a Female patient taking Increlex (View Usage) (Dosage: (0.2 Mg/kg, Daily), Subcutaneous) was diagnosed with rett's disorder and. Location: ITALY , child 6 years of age, Patient experienced the following unwanted or unexpected effects: clonus. During the same period patient was treated with SEASONAL VACCINE (VACCINES) (View Seasonal Vaccine (vaccines) Review and Seasonal Vaccine (vaccines) Label ). Patient was hospitalized.

6917799-2 | Angioedema, Dyspnoea, Incorrect Product Storage, Injection Site Pruritus
on Jul 26, 2010 Male patient from FRANCE , 15 years of age, weighting 59.52 lb, was diagnosed with congenital osteodystrophy and was treated with Increlex (View Usage). Patient had the following side effects: angioedema, dyspnoea, incorrect product storage, injection site pruritus. Increlex dosage: See Image. During the same period patient was treated with VENTOLIN (View Ventolin Review and Ventolin Label ).

6883729-5 | Dizziness, Injection Site Urticaria, Loss Of Consciousness, Pruritus
on Jul 15, 2010 Male patient from UNITED STATES , 17 years of age, weighting 70.55 lb, was diagnosed with insulin-like growth factor decreased and was treated with Increlex (View Usage). After Increlex was administered, patient had the following side effects: dizziness (What is dizziness?), injection site urticaria, loss of consciousness, pruritus. Increlex dosage: (2 In 1 D), Parenteral.

6831059-X | Intracranial Pressure Increased, Migraine, Neck Pain, Nuchal Rigidity, Papilloedema, Vomiting
Patient was taking Increlex (View Usage). Patient experienced the following unwanted or unexpected effects: intracranial pressure increased, migraine (What is migraine?), neck pain, nuchal rigidity, papilloedema, vomiting on Jun 14, 2010 from UNITED STATES Additional patient health information: Male patient , child 11 years of age, weighting 63.93 lb, was diagnosed with insulin-like growth factor decreased and. Increlex dosage: . During the same period patient was treated with CONCERTA (View Concerta Review and Concerta Label ). Patient was hospitalized.

6828158-5 | Adenoidal Hypertrophy, Tonsillar Hypertrophy
Adverse event was reported on Jul 08, 2010 by a Male patient taking Increlex (View Usage) (Dosage: 18 Units -0.11 Mg/kg Bid Sq) was diagnosed with body height below normal, insulin-like growth factor increased and. Location: UNITED STATES , weighting 37.48 lb, Patient had the following side effects: adenoidal hypertrophy, tonsillar hypertrophy.

6807425-5 | Dizziness, Injection Site Urticaria, Loss Of Consciousness, Pruritus
on Jun 15, 2010 Male patient from UNITED STATES , 17 years of age, weighting 70.55 lb, was diagnosed with growth hormone deficiency and was treated with Increlex (View Usage). After Increlex was administered, patient had the following side effects: dizziness (What is dizziness?), injection site urticaria, loss of consciousness, pruritus. Increlex dosage: 2 In 1 D, Parenteral.

6784920-9 | Chest Pain, Decreased Activity, Ventricular Hypertrophy
on Jun 04, 2010 Male patient from UNITED STATES , 13 years of age, weighting 84.22 lb, was diagnosed with growth hormone deficiency and was treated with Increlex (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), decreased activity, ventricular hypertrophy. Increlex dosage: 92 Units (46 Units, 2 In 1 D, Subcutaneous.

6776141-0 | Urticaria
Patient was taking Increlex (View Usage). Patient had the following side effects: urticaria on Jun 01, 2010 from UNITED STATES Additional patient health information: Female patient , child 11 years of age, weighting 50.04 lb, was diagnosed with growth hormone deficiency and. Increlex dosage: 160 Ug/kg (80 Ug/kg, 2 In 1 D), Subcutaneous.

6776134-3 | Diplopia, Headache, Intracranial Pressure Increased, Neck Pain
Adverse event was reported on Jun 03, 2010 by a Male patient taking Increlex (View Usage) (Dosage: ) was diagnosed with insulin-like growth factor decreased and. Location: UNITED STATES , child 11 years of age, weighting 63.93 lb, After Increlex was administered, patient had the following side effects: diplopia, headache (What is headache?), intracranial pressure increased, neck pain. During the same period patient was treated with CONCERTA (METHYLPENIDATE HYDROCHLORIDE) (View Concerta (methylpenidate Hydrochloride) Review and Concerta (methylpenidate Hydrochloride) Label ). Patient was hospitalized.

6759885-6 | Depression, Headache, Suicidal Ideation
on May 21, 2010 Male patient from UNITED STATES , 17 years of age, weighting 125.0 lb, was diagnosed with growth hormone deficiency and was treated with Increlex (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), headache (What is headache?), suicidal ideation. Increlex dosage: See Image.

6759453-6 | Diplopia
on May 19, 2010 Male patient from UNITED STATES , child 11 years of age, was diagnosed with growth hormone deficiency and was treated with Increlex (View Usage). Patient had the following side effects: diplopia. Increlex dosage: .

6752742-0 | Depression, Suicidal Ideation
Patient was taking Increlex (View Usage). After Increlex was administered, patient had the following side effects: depression (What is depression?), suicidal ideation on May 14, 2010 from UNITED STATES Additional patient health information: Male patient , 16 years of age, weighting 125.0 lb, was diagnosed with growth hormone deficiency and. Increlex dosage: 80 Mg (40 Mg, 2 In 1 D), Subcutaneous, 100 Mg (50 Mg, 2 In 1 D), Subcutaneous.

6721260-8 | Clonus, Hypotonia, Partial Seizures, Somnolence
Adverse event was reported on Apr 29, 2010 by a Female patient taking Increlex (View Usage) (Dosage: 0.2 Ug/kg (0.2 Ug/kg, 1 In 1 D), Subcutaneous) was diagnosed with rett's disorder and. Location: ITALY , child 4 years of age, weighting 44.09 lb, Patient experienced the following unwanted or unexpected effects: clonus, hypotonia, partial seizures, somnolence. Patient was hospitalized.

6721253-0 | Cardiac Failure, Cystic Fibrosis Lung, Haemolytic Anaemia, Hepatic Enzyme Abnormal, Interstitial Lung Disease
on May 03, 2010 Female patient from GERMANY , child 8 years of age, weighting 20.94 lb, was diagnosed with growth hormone deficiency and was treated with Increlex (View Usage). Patient had the following side effects: cardiac failure, cystic fibrosis lung, haemolytic anaemia, hepatic enzyme abnormal, interstitial lung disease. Increlex dosage: 120 Ug/kg (not Reported, 2 In 1 D), Subcutaneous (53 Ug/kg, 1 In 1 D), Subcutaneous. Patient was hospitalized.

6720606-4 | Erythema, Induration, Pain, Pruritus, Skin Reaction, Swelling
on Apr 29, 2010 Male patient from UNITED STATES , child 12 years of age, weighting 78.26 lb, was diagnosed with body height below normal and was treated with Increlex (View Usage). After Increlex was administered, patient had the following side effects: erythema, induration, pain (What is pain?), pruritus, skin reaction, swelling. Increlex dosage: 2.4 Mg (1.2 Mg, 2 In 1 D), Subcutaneous.

6710534-2 | Clonic Convulsion, Partial Seizures, Petit Mal Epilepsy
Patient was taking Increlex (View Usage). Patient experienced the following unwanted or unexpected effects: clonic convulsion, partial seizures, petit mal epilepsy on Apr 15, 2010 from ITALY Additional patient health information: Female patient , child 4 years of age, was diagnosed with rett's disorder and. Increlex dosage: 0.2 Ug/kg (0.2 Ug/kg, 1 In 1 D), Subcutaneous. Patient was hospitalized.

6710023-5 | Erythema, Induration, Pruritus
Adverse event was reported on Apr 16, 2010 by a Male patient taking Increlex (View Usage) (Dosage: 10 Mg/ml, Subcutaneous) was diagnosed with insulin-like growth factor decreased and. Location: UNITED STATES , child 12 years of age, Patient had the following side effects: erythema, induration, pruritus.

6699379-X | Intracranial Pressure Increased, Papilloedema
on Apr 13, 2010 Male patient from UNITED STATES , 13 years of age, was diagnosed with body height below normal and was treated with Increlex (View Usage). After Increlex was administered, patient had the following side effects: intracranial pressure increased, papilloedema. Increlex dosage: 100 Units (100 Units, 1 In 1 D), Subcutaneous. Patient was hospitalized.

6686533-6 | Intracranial Pressure Increased
on Apr 01, 2010 Male patient from UNITED STATES , 13 years of age, was diagnosed with body height below normal and was treated with Increlex (View Usage). Patient experienced the following unwanted or unexpected effects: intracranial pressure increased. Increlex dosage: 100 Units (100 Units,1 In 1 D), Subcutaneous. Patient was hospitalized.

6668830-3 | Intracranial Pressure Increased, Tinnitus
Patient was taking Increlex (View Usage). Patient had the following side effects: intracranial pressure increased, tinnitus (What is tinnitus?) on Mar 25, 2010 from UNITED STATES Additional patient health information: Male patient , 13 years of age, was diagnosed with body height below normal and. Increlex dosage: 100 Units (100 Units, 1 In 1 D), Subcutaneous.

6647915-1 | Thyroid Neoplasm
Adverse event was reported on Feb 11, 2010 by a Male patient taking Increlex (View Usage) (Dosage: 224.6ug/kg (32 Iu, 2 In 1 D)) was diagnosed with growth hormone deficiency and. Location: GERMANY , child 8 years of age, weighting 62.83 lb, After Increlex was administered, patient had the following side effects: thyroid neoplasm.

6646143-3 | Urticaria
on Mar 04, 2010 Female patient from UNITED STATES , child 11 years of age, was treated with Increlex (View Usage). Patient experienced the following unwanted or unexpected effects: urticaria. Increlex dosage: (120 Ug/k), Subcutaneous.

6619281-9 | Hydrocele Female
on Feb 18, 2010 Male patient from FRANCE , child 10 years of age, weighting 39.68 lb, was diagnosed with growth hormone deficiency and was treated with Increlex (View Usage). Patient had the following side effects: hydrocele female. Increlex dosage: (0.12 Mg/kg,), Subcutaneous. During the same period patient was treated with CREON (View Creon Review and Creon Label ), UVESTEROL (UVESTEROL) (View Uvesterol (uvesterol) Review and Uvesterol (uvesterol) Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), BECONASE (View Beconase Review and Beconase Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6613204-4 | Thyroid Neoplasm
Patient was taking Increlex (View Usage). After Increlex was administered, patient had the following side effects: thyroid neoplasm on Feb 11, 2010 from GERMANY Additional patient health information: Male patient , child 8 years of age, weighting 62.83 lb, was diagnosed with growth hormone deficiency and. Increlex dosage: 128 Iu (32 Iu, 4 In 1 D).

6592714-2 | Hypoglycaemia
Adverse event was reported on Jan 27, 2010 by a Female patient taking Increlex (View Usage) (Dosage: 12 Hourly) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED KINGDOM , 13 years of age, Patient experienced the following unwanted or unexpected effects: hypoglycaemia.

6584660-5 | Hydrocele
on Jan 23, 2010 Male patient from FRANCE , child 10 years of age, was treated with Increlex (View Usage). Patient had the following side effects: hydrocele. Increlex dosage: (0.12 Mg/kg). Patient was hospitalized.

6552322-6 | Angioedema, Cough, Hypersensitivity, Injection Site Erythema, Injection Site Haematoma, Injection Site Induration, Injection Site Urticaria, Injection Site Warmth, Swelling Face
on Jan 04, 2010 Male patient from UNITED STATES , child 10 years of age, weighting 43.65 lb, was diagnosed with dwarfism (What is dwarfism?) and was treated with Increlex (View Usage). After Increlex was administered, patient had the following side effects: angioedema, cough, hypersensitivity, injection site erythema, injection site haematoma, injection site induration, injection site urticaria, injection site warmth, swelling face. Increlex dosage: See Image.

6538101-4 | Dyspnoea, Eyelid Oedema, Injection Site Pruritus, Lip Oedema, Urticaria
Patient was taking Increlex (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, eyelid oedema, injection site pruritus, lip oedema, urticaria on Dec 28, 2009 from FRANCE Additional patient health information: Male patient , 15 years of age, was diagnosed with congenital osteodystrophy and. Increlex dosage: See Image. During the same period patient was treated with VENTOLIN (View Ventolin Review and Ventolin Label ).

6537008-6 | Retinopathy Proliferative
Adverse event was reported on Dec 23, 2009 by a Female patient taking Increlex (View Usage) (Dosage: 0.18mg/kg/day (5 Mg,2 In 1 D),subcutaneous; 0.08mg/kg/day (2.5 Mg,2 In 1 D),subcutaneous) . Location: FRANCE , 18 years of age, Patient had the following side effects: retinopathy proliferative. Patient was hospitalized.

6510076-3 | Accidental Overdose, Hypoglycaemia
on Dec 07, 2009 Male patient from SPAIN , child 3 years of age, was diagnosed with blood growth hormone abnormal and was treated with Increlex (View Usage). After Increlex was administered, patient had the following side effects: accidental overdose, hypoglycaemia. Increlex dosage: 0.8 Mg (0.4 Mg, 2 In 1 D), Subcutaneous. During the same period patient was treated with VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ). Patient was hospitalized.

6450673-7 | Benign Intracranial Hypertension, Papilloedema
on Nov 20, 2009 Female patient from UNITED STATES , weighting 93.70 lb, was diagnosed with body height below normal, insulin-like growth factor decreased and was treated with Increlex (View Usage). Patient experienced the following unwanted or unexpected effects: benign intracranial hypertension, papilloedema. Increlex dosage: 5.2 Mg Bid Sq. Patient was hospitalized.

6430216-4 | Dysplastic Naevus Syndrome, Melanocytic Naevus
Patient was taking Increlex (View Usage). Patient had the following side effects: dysplastic naevus syndrome, melanocytic naevus on Oct 19, 2009 from UNITED STATES Additional patient health information: Male patient , 17 years of age, weighting 121.3 lb, was diagnosed with growth hormone deficiency and. Increlex dosage: 60 Units (60 Units,1 In 1 D),subcutaneous ; 60 Units (30 Units,2 In 1 D),subcutaneous. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), PERIACTIN (View Periactin Review and Periactin Label ), FLONASE (View Flonase Review and Flonase Label ).

6409501-8 | Dysplastic Naevus Syndrome, Melanocytic Naevus
Adverse event was reported on Oct 01, 2009 by a Male patient taking Increlex (View Usage) (Dosage: 60 Units (60 Units, 1 In 1 D),subcutaneous; 60 Units (30 Units, 2 In 1 D),subcutaneous) was diagnosed with body height below normal and. Location: UNITED STATES , 17 years of age, weighting 121.3 lb, After Increlex was administered, patient had the following side effects: dysplastic naevus syndrome, melanocytic naevus. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), PERIACTIN (View Periactin Review and Periactin Label ), FLONASE (View Flonase Review and Flonase Label ).

6400914-7 | Rathke's Cleft Cyst
on Sep 23, 2009 Male patient from UNITED STATES , 14 years of age, weighting 85.98 lb, was treated with Increlex (View Usage). Patient experienced the following unwanted or unexpected effects: rathke's cleft cyst. Increlex dosage: 90 Units (45 Units, 2 In 1d) Subcutaneous, 30 Units (15 Unints, 2 In 1 D), Subcutaneous.

6394378-X | Abdominal Discomfort, Hypoglycaemia, Loss Of Consciousness
on Sep 15, 2009 Male patient from TAIWAN, PROVINCE OF CHINA , child 7 years of age, was diagnosed with dwarfism (What is dwarfism?), insulin-like growth factor decreased and was treated with Increlex (View Usage). Patient had the following side effects: abdominal discomfort, hypoglycaemia, loss of consciousness. Increlex dosage: 240 Ug/kg (120 Ug/kg, 2 In 1 D) Subcutaneous. Patient was hospitalized.

6389027-0 | Abdominal Discomfort, Hypoglycaemia, Loss Of Consciousness
Patient was taking Increlex (View Usage). After Increlex was administered, patient had the following side effects: abdominal discomfort, hypoglycaemia, loss of consciousness on Sep 15, 2009 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Male patient , child 7 years of age, was diagnosed with insulin-like growth factor increased and. Increlex dosage: 240 Ug/kg (120 Ug/kg,2 In 1 D).

6344831-X | Anaphylactic Reaction, Injection Site Erythema, Pharyngeal Hypoaesthesia
Adverse event was reported on Jul 28, 2009 by a Male patient taking Increlex (View Usage) (Dosage: 2.6 Mg (1.3 Mg, 2 In 1 D), Subcutaneous) . Location: UNITED STATES , 13 years of age, weighting 74.96 lb, Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, injection site erythema, pharyngeal hypoaesthesia. Patient was hospitalized.

6318538-9 | Lipohypertrophy, Skin Hypertrophy
on Aug 04, 2009 Male patient from SWEDEN , child 10 years of age, was diagnosed with insulin-like growth factor decreased and was treated with Increlex (View Usage). Patient had the following side effects: lipohypertrophy, skin hypertrophy. Increlex dosage: 29 Iex2 (not Reported) Subcutaneous.

6305648-5 | Respiratory Distress
on Jul 28, 2009 Male patient from UNITED STATES , 13 years of age, weighting 74.96 lb, was treated with Increlex (View Usage). After Increlex was administered, patient had the following side effects: respiratory distress. Increlex dosage: 2.6 Mg (1.3 Mg, 2 In 1 D), Subcutaneous. Patient was hospitalized.

6300307-7 | Encephalitis, Haemodynamic Instability
Patient was taking Increlex (View Usage). Patient experienced the following unwanted or unexpected effects: encephalitis (What is encephalitis?), haemodynamic instability on Jun 22, 2009 from SPAIN Additional patient health information: Male patient , child 9 years of age, weighting 52.91 lb, was diagnosed with insulin-like growth factor decreased and. Increlex dosage: See Image. Patient was hospitalized.

6286997-6 | Accidental Overdose, Hypoglycaemia
Adverse event was reported on Nov 25, 2008 by a Male patient taking Increlex (View Usage) (Dosage: See Image) . Location: SPAIN , child 3 years of age, weighting 16.53 lb, Patient had the following side effects: accidental overdose, hypoglycaemia. Patient was hospitalized.

6286315-3 | Back Pain, Facial Palsy, Jaw Disorder, Nerve Compression, Oedema Peripheral
on Nov 05, 2007 Male patient from UNITED STATES , child 10 years of age, weighting 63.49 lb, was treated with Increlex (View Usage). After Increlex was administered, patient had the following side effects: back pain (What is back pain?), facial palsy, jaw disorder, nerve compression, oedema peripheral. Increlex dosage: See Image. During the same period patient was treated with CONCERTA (View Concerta Review and Concerta Label ), ALLEGRA (View Allegra Review and Allegra Label ), FLONASE PRAY (FLUTICASONE PROPIONATE) (View Flonase Pray (fluticasone Propionate) Review and Flonase Pray (fluticasone Propionate) Label ), GUMMY BEARS MULTIVITAMIN AND MINERAL (MULTIVITAMIN AND MINERAL SUPPLEM (View Gummy Bears Multivitamin And Mineral (multivitamin And Mineral Supplem Review and Gummy Bears Multivitamin And Mineral (multivitamin And Mineral Supplem Label ), OMEGA 3 AND 6 (CARBINOXAMINE MALEATE) (View Omega 3 And 6 (carbinoxamine Maleate) Review and Omega 3 And 6 (carbinoxamine Maleate) Label ).

6286308-6 | Blood Potassium Decreased, Convulsion, Dyskinesia, Pain In Extremity
on Feb 17, 2009 Female patient from UNITED STATES , child 10 years of age, weighting 56.75 lb, was treated with Increlex (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium decreased, convulsion, dyskinesia, pain in extremity. Increlex dosage: 217.552ug/kg (2800 ?g, 2 In 1 D), Subcutaneous.

6238232-2 | Epiphysiolysis, Joint Range Of Motion Decreased, Osteonecrosis
Patient was taking Increlex (View Usage). Patient had the following side effects: epiphysiolysis, joint range of motion decreased, osteonecrosis (What is osteonecrosis?) on Jun 02, 2009 from UNITED STATES Additional patient health information: Male patient , 13 years of age, weighting 112.4 lb, was diagnosed with body height below normal and. Increlex dosage: 6 Mg, Bid, Subcutaneous. Patient was hospitalized.